Sign up
Log in
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • Community Health Sys (NYSE:CYH) shares rose 13.2% to $2.75 during Wednesday's after-market session. The company's market cap stands at $382.0 million. As per the press release, Q1 earnings came out today.
  • Candel Therapeutics (NASDAQ:CADL) stock increased by 11.55% to $5.31. The company's market cap stands at $250.8 million.
  • Ovid Therapeutics (NASDAQ:OVID) stock increased by 8.61% to $0.35. The company's market cap stands at $25.0 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 7.6% to $0.28. The company's market cap stands at $73.8 million.
  • Vanda Pharmaceuticals (NASDAQ:VNDA) stock increased by 7.18% to $4.64. The market value of their outstanding shares is at $270.6 million.
  • Clearside Biomedical (NASDAQ:CLSD) shares rose 6.83% to $0.85. The company's market cap stands at $65.6 million.

Losers

  • Relmada Therapeutics (NASDAQ:RLMD) shares declined by 20.4% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $17.8 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 19.62% to $2.95. The company's market cap stands at $4.1 million.
  • Citius Oncology (NASDAQ:CTOR) stock fell 9.33% to $0.61. The market value of their outstanding shares is at $43.4 million.
  • Zhengye Biotechnology (NASDAQ:ZYBT) shares fell 8.03% to $7.34. The company's market cap stands at $347.8 million.
  • 60 Degrees (NASDAQ:SXTP) shares fell 6.98% to $2.8. The market value of their outstanding shares is at $4.1 million.
  • INVO Fertility (NASDAQ:NAYA) stock decreased by 6.12% to $1.8. The company's market cap stands at $8.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.